273 related articles for article (PubMed ID: 29687326)
21. Contemporary practice patterns related to the risk of acute kidney injury in the catheterization laboratory: Results from a survey of Society of Cardiovascular Angiography and Intervention (SCAI) cardiologists.
Prasad A; Sohn A; Morales J; Williams K; Bailey SR; Levin D; McCullough PA; Mehran R; Lopez-Cruz G; Harder J
Catheter Cardiovasc Interv; 2017 Feb; 89(3):383-392. PubMed ID: 27315581
[TBL] [Abstract][Full Text] [Related]
22. An economic analysis of strategies for the use of contrast media for diagnostic cardiac catheterization.
Barrett BJ; Parfrey PS; Foley RN; Detsky AS
Med Decis Making; 1994; 14(4):325-35. PubMed ID: 7808208
[TBL] [Abstract][Full Text] [Related]
23. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
[TBL] [Abstract][Full Text] [Related]
24. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
[TBL] [Abstract][Full Text] [Related]
25. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Chen Y; Hu S; Liu Y; Zhao R; Wang L; Fu G; He Q; Su X; Zheng Y; Qi X; Liu H; Wang J; Gao W; Wang M; Liu S; Zheng X; He B; Yang P; Zhou S; Gao C; Qiu C
EuroIntervention; 2012 Nov; 8(7):830-8. PubMed ID: 23045301
[TBL] [Abstract][Full Text] [Related]
26. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
Werner S; Bez C; Hinterleitner C; Horger M
PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
[TBL] [Abstract][Full Text] [Related]
27. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
Zhang BC; Wu Q; Wang C; Li DY; Wang ZR
J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991
[TBL] [Abstract][Full Text] [Related]
28. Iodixanol versus Iopromide at Coronary CT Angiography: Lumen Opacification and Effect on Heart Rhythm-the Randomized IsoCOR Trial.
Lubbers MM; Kock M; Niezen A; Galema T; Kofflard M; Bruning T; Kooij HS; van Valen H; Dijkshoorn M; Booij R; Padmos A; Vogels A; Budde RPJ; Nieman K
Radiology; 2018 Jan; 286(1):71-80. PubMed ID: 28809582
[TBL] [Abstract][Full Text] [Related]
29. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.
Solomon R
Kidney Int; 2005 Nov; 68(5):2256-63. PubMed ID: 16221227
[TBL] [Abstract][Full Text] [Related]
30. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
[TBL] [Abstract][Full Text] [Related]
31. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
[TBL] [Abstract][Full Text] [Related]
32. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
[TBL] [Abstract][Full Text] [Related]
33. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
Rudnick MR; Davidson C; Laskey W; Stafford JL; Sherwin PF;
Am Heart J; 2008 Oct; 156(4):776-82. PubMed ID: 18946896
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Iodixanol and Iopromide in Patients With Renal Insufficiency and Congestive Heart Failure Undergoing Coronary Angiography by Hemodynamic Monitoring.
Qian G; Yang YQ; Dong W; Cao F; Chen YD
Angiology; 2017 Nov; 68(10):907-913. PubMed ID: 28401790
[TBL] [Abstract][Full Text] [Related]
35. Recent clinical trials of iodixanol.
Erdogan A; Davidson CJ
Rev Cardiovasc Med; 2003; 4 Suppl 5():S43-50. PubMed ID: 14668709
[TBL] [Abstract][Full Text] [Related]
36. Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture.
Ludwig U; Connemann J; Keller F
Clin Exp Nephrol; 2013 Dec; 17(6):779-82. PubMed ID: 23345070
[TBL] [Abstract][Full Text] [Related]
37. Renal safety of iodixanol.
McCullough PA
Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
[TBL] [Abstract][Full Text] [Related]
38. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
[TBL] [Abstract][Full Text] [Related]
39. Nephrotoxic effects in high-risk patients undergoing angiography.
Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty.
Song T; Song M; Ge Z; Li Y; Shi P; Sun M
J Interv Cardiol; 2017 Jun; 30(3):281-285. PubMed ID: 28421628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
